Revolution Medicines RVMD Balance Sheet (2019-2026)

NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT
Reported Financials

Revolution Medicines Quarterly Balance Sheet

Periods 30 quarters
Latest Jun 2026

Revolution Medicines reported total assets of $4323.27M and total liabilities of $1717.03M for the quarter ended Jun 2026, up 77.9% year over year. This balance sheet covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
129.15M108.50M97.67M105.78M178.94M161.41M427.22M380.33M358.40M696.15M288.43M275.71M201.26M543.06M333.55M402.44M217.44M383.75M440.94M815.44M
Short-term InvestmentsInvestments (Current)
479.50M468.56M421.09M355.65M476.07M483.53M482.58M529.16M454.80M1,156.81M1,415.11M1,315.00M1,348.22M1,746.24M1,769.12M1,734.73M1,714.07M1,641.93M1,467.15M3,122.53M
Cash & Current Investments
608.66M577.05M518.75M461.43M655.01M644.94M909.80M909.49M813.20M1,852.96M1,703.54M1,590.72M1,549.48M2,289.30M2,102.68M2,137.17M1,931.51M2,025.68M1,908.08M3,937.97M
Receivables - OtherOther Receivables
Prepaid Assets
7.47M6.79M10.21M15.99M15.16M10.57M8.96M10.09M10.96M25.07M25.66M34.02M29.66M38.33M31.91M39.27M45.98M49.36M59.83M90.37M
Current Assets
623.54M589.77M534.34M483.05M675.11M660.19M922.75M922.09M824.47M1,879.28M1,729.20M1,624.73M1,579.14M2,327.63M2,134.58M2,176.44M1,977.49M2,075.04M1,967.91M4,028.34M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
10.11M11.54M13.06M15.91M18.27M18.66M18.54M19.72M20.29M22.87M23.70M25.28M24.81M24.29M27.15M33.05M32.93M33.19M31.48M34.61M
Goodwill
14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M14.61M
Intangibles
60.14M59.88M59.61M59.34M58.54M58.81M58.54M58.27M58.01M57.74M57.47M57.21M56.94M56.67M56.40M56.14M55.87M55.80M55.80M55.80M
Goodwill & Intangibles
74.75M74.48M74.22M73.95M73.15M73.42M73.15M72.88M72.61M72.35M72.08M71.81M71.55M71.28M71.01M70.74M70.48M70.41M70.41M70.41M
Other Non-Current Assets
1.08M1.74M4.33M4.20M4.33M6.33M4.51M5.29M13.74M10.06M7.19M11.31M13.16M17.57M16.83M35.34M36.58M43.79M54.05M62.07M
Non-Current Assets
111.44M148.22M148.43M149.76M150.80M151.75M150.50M151.62M159.77M182.42M179.16M183.71M183.86M230.67M230.77M253.13M274.43M279.47M285.82M294.93M
Assets
734.98M737.99M682.77M632.80M825.91M811.93M1,073.25M1,073.71M984.23M2,061.71M1,908.36M1,808.44M1,763.00M2,558.30M2,365.35M2,429.57M2,251.92M2,354.51M2,253.74M4,323.27M
Liabilities
Current Liabilities
Accounts Payables
10.49M14.06M14.17M14.07M24.38M21.31M19.91M29.78M29.63M61.79M32.38M29.32M24.46M54.43M47.51M56.76M74.85M64.62M80.54M88.42M
Payables
10.49M14.06M14.17M14.07M24.38M21.31M19.91M29.78M29.63M61.79M32.38M29.32M24.46M54.43M47.51M56.76M74.85M64.62M80.54M88.42M
Accumulated Expenses
23.78M27.72M25.52M33.76M32.19M29.45M27.37M42.56M50.16M74.69M53.18M67.68M78.01M96.62M98.11M114.69M159.45M209.34M197.45M248.89M
Other Accumulated Expenses
0.13M0.31M0.28M0.65M0.49M0.51M0.40M0.35M0.48M3.90M0.74M0.66M1.28M0.58M0.65M0.46M8.24M7.86M3.26M5.15M
Current Deferred Revenue
12.67M12.36M11.43M9.69M9.69M4.46M1.43M
Total Current Liabilities
51.89M60.35M57.46M63.54M73.27M61.98M54.64M78.06M85.54M143.85M93.72M105.33M110.86M163.91M158.60M184.53M245.62M290.42M289.60M354.06M
Non-Current Liabilities
Convertible Debt
487.43M
Non-Current Deffered Revenue
9.68M6.57M5.66M3.84M5.42M
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
7.44M7.44M7.44M7.44M7.15M7.03M7.03M7.03M3.16M3.12M3.12M3.12M3.12M2.35M2.35M2.35M2.35M2.35M2.35M2.35M
Operating Leases
26.83M60.42M59.58M58.92M58.18M57.43M57.68M57.54M57.09M80.58M79.86M79.08M78.31M122.97M121.36M119.70M142.14M142.23M140.02M137.74M
Other Non-Current Liabilities
0.93M0.63M1.63M0.22M0.47M0.30M1.69M0.25M0.98M7.97M6.20M2.06M4.41M3.86M4.89M12.53M8.40M19.75M41.21M186.90M
Total Non-Current Liabilities
95.84M134.79M130.15M133.74M144.02M126.44M119.34M142.62M145.79M227.54M176.70M187.53M192.29M289.24M282.32M551.67M646.62M703.46M712.61M1,530.13M
Total Liabilities
96.77M135.42M131.78M133.96M144.49M126.74M121.03M142.87M146.77M235.51M182.90M189.59M196.70M293.10M287.20M564.20M655.02M723.21M753.82M1,717.03M
Shareholder's Equity
Common Equity
638.20M602.57M550.99M498.84M681.42M685.19M952.22M930.84M837.46M1,826.19M1,725.47M1,618.85M1,566.30M2,265.20M2,078.15M1,865.37M1,596.90M1,631.30M1,499.92M2,606.24M
Liabilities and Shareholders Equity
734.98M737.99M682.77M632.80M825.91M811.93M1,073.25M1,073.71M984.23M2,061.71M1,908.36M1,808.44M1,763.00M2,558.30M2,365.35M2,429.57M2,251.92M2,354.51M2,253.74M4,323.27M
Retained Earnings
-400.00M-452.64M-510.30M-571.51M-644.83M-701.34M-769.44M-867.74M-976.20M-1,137.71M-1,300.00M-1,400.00M-1,543.23M-1,737.80M-2,000.00M-2,200.00M-2,504.21M-2,869.10M-3,322.92M-4,000.00M

Revolution Medicines Balance Sheet API

Pull Revolution Medicines's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RVMD&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY